Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.

NCT00002147 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: Doxorubicin hydrochloride (liposomal)

Sponsor

Sequus Pharmaceuticals